Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.42
+0.0%
$96.74
$81.97
$139.06
$152.27B0.6512.95 million shs9.52 million shs
Novartis AG stock logo
NVS
Novartis
$152.14
+0.1%
$150.02
$111.06
$170.46
$290.31B0.461.35 million shs1.41 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$448.55
+0.1%
$480.25
$385.46
$643.99
$166.69B0.882.42 million shs1.69 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+3.47%-4.10%-24.07%-33.43%
Novartis AG stock logo
NVS
Novartis
0.00%+2.80%+4.67%-7.57%+34.92%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.00%+2.37%-4.41%-13.15%+13.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.42
+0.0%
$96.74
$81.97
$139.06
$152.27B0.6512.95 million shs9.52 million shs
Novartis AG stock logo
NVS
Novartis
$152.14
+0.1%
$150.02
$111.06
$170.46
$290.31B0.461.35 million shs1.41 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$448.55
+0.1%
$480.25
$385.46
$643.99
$166.69B0.882.42 million shs1.69 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+3.47%-4.10%-24.07%-33.43%
Novartis AG stock logo
NVS
Novartis
0.00%+2.80%+4.67%-7.57%+34.92%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.00%+2.37%-4.41%-13.15%+13.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.4336.62% Upside
Novartis AG stock logo
NVS
Novartis
2.31
Hold$141.20-7.19% Downside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.96
Moderate Buy$616.1037.35% Upside

Current Analyst Ratings Breakdown

Latest NVS, TMO, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Set Price TargetSector Perform$490.00
5/14/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UpgradeHold
5/8/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Lower Price TargetOverweight$675.00 ➝ $615.00
4/29/2026
Novartis AG stock logo
NVS
Novartis
DowngradeBuy (A-)Buy (B)
4/27/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Reiterated RatingOverweight$620.00
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/24/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UpgradeStrong-Buy
4/24/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Lower Price TargetBuy$700.00 ➝ $600.00
4/24/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Lower Price TargetOutperform$653.00 ➝ $639.00
4/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeOutperformNeutral$92.00
(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$45.13B3.37$6.99 per share12.50$30.26 per share2.89
Novartis AG stock logo
NVS
Novartis
$54.53B5.32$10.75 per share14.15$20.40 per share7.46
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$45.20B3.69$30.41 per share14.75$139.77 per share3.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5724.4914.431.4613.90%17.62%10.01%7/16/2026 (Estimated)
Novartis AG stock logo
NVS
Novartis
$13.98B$6.9821.8015.482.6724.87%38.82%15.16%7/21/2026 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.1924.6616.441.9815.15%16.86%8.15%7/22/2026 (Estimated)

Latest NVS, TMO, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/27/2026Q1 2026
Novartis AG stock logo
NVS
Novartis
$2.11$1.99-$0.12$1.65$13.44 billion$13.52 billion
4/23/2026Q1 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.25$5.44+$0.19$4.43$10.86 billion$11.01 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.88%+10.39%70.59%54 Years
Novartis AG stock logo
NVS
Novartis
$3.082.02%+5.28%44.13%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.42%+14.34%10.34%8 Years

Latest NVS, TMO, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.42%6/15/20266/15/20267/15/2026
2/25/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.41%3/13/20263/13/20264/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Novartis AG stock logo
NVS
Novartis
0.96
0.85
0.65
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.77
1.53
1.15

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Novartis AG stock logo
NVS
Novartis
13.12%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Novartis AG stock logo
NVS
Novartis
0.01%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Novartis AG stock logo
NVS
Novartis
75,2671.91 billion1.91 billionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000371.62 million370.40 millionOptionable

Recent News About These Companies

Thermo Fisher Scientific Announces Quarterly Dividend

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$87.42 +0.01 (+0.01%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$87.76 +0.34 (+0.39%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Novartis stock logo

Novartis NYSE:NVS

$152.14 +0.13 (+0.09%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$152.00 -0.14 (-0.09%)
As of 05/22/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$448.55 +0.27 (+0.06%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$448.80 +0.25 (+0.05%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.